Johnson and Johnson are pairing with Glaxo to test a monthly AIDS treatment. Any success will be huge for patients and investors alike.
Any developments in this arena are positive. If Johnson and Johnson continues successfully there will be a massive rise in value.
rumor has it JNJ will buy CYTR for their cancer drug aldoxorubicin
Moves like this are promising.
We'll all find out around 4/25.
Current estimate on Bloomberg is for 5 cents, the same increase as last year; 6.5 would be nice.
Just don't have the patience to wait . I may not live long enough. There are many better places to put money. Thanks for your reply